beta-(4-fluorobenzoyl)propionic acid has been researched along with Disease Models, Animal in 2 studies
*Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haapalinna, A; Haaparanta, M; Marjamäki, P; Niemi, R; Rinne, J; Solin, O | 1 |
| Baik, JH; Choi, JH; Han, PL; Kim, HS; Kim, JI; Kim, YS; Kwon, J; Lee, KW; Lee, SJ; Lee, T; Ryu, SH; Shin, SW; Song, M; Suh, PG; Yumkham, S | 1 |
2 other study(ies) available for beta-(4-fluorobenzoyl)propionic acid and Disease Models, Animal
| Article | Year |
|---|---|
Uptake of 6-[18F]fluoro-L-dopa and [18F]CFT reflect nigral neuronal loss in a rat model of Parkinson's disease.
Topics: Amphetamine; Animals; Apomorphine; Autoradiography; Behavior, Animal; Brain; Brain Mapping; Central Nervous System Stimulants; Dihydroxyphenylalanine; Disease Models, Animal; Dopamine Agonists; Functional Laterality; Immunohistochemistry; Levodopa; Male; Oxidopamine; Parkinson Disease; Propionates; Radioligand Assay; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2004 |
Identification of a new functional target of haloperidol metabolite: implications for a receptor-independent role of 3-(4-fluorobenzoyl) propionic acid.
Topics: Animals; Brain; Catalepsy; Cell Line, Transformed; Disease Models, Animal; Dopamine Antagonists; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Haloperidol; Male; MAP Kinase Kinase 1; Mice; Mice, Inbred C57BL; Molecular Structure; Motor Activity; Neurons; Phosphorylation; Propionates; Receptors, Dopamine D2 | 2006 |